Related Experiment Video
Updated: Jun 23, 2026
Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations
Published on: October 20, 2017
Microcoil embolisation of mycotic cystic artery pseudoaneurysm: a viable option in high-risk patients
Russell Mullen1, Stuart A Suttie, Raj Bhat
1Department of General Surgery, Queen Margaret Hospital, Whitefield Road, Dunfermline, KY12 0SU, UK. russmullen@doctors.org.uk
Abstract:
Mycotic cystic artery pseudoaneurysm is a rare complication of cholecystitis, of which the main treatment has been cholecystectomy plus ligation of the cystic artery. We highlight our experience with successful coil embolisation of this condition without the need for surgical intervention. This is followed by a comprehensive review of the literature regarding management of this unusual condition.
Insights
Mycotic cystic artery pseudoaneurysm, a rare cholecystitis complication, can be successfully treated with coil embolization. This minimally invasive approach avoids surgery, offering a new management option for this unusual condition.
Area of Science:
- Vascular surgery
- Interventional radiology
- Gastroenterology
Background:
- Mycotic cystic artery pseudoaneurysm is a rare but serious complication of cholecystitis.
- Traditional management involves cholecystectomy and cystic artery ligation, carrying significant risks.
Observation:
- The study presents a case of successful mycotic cystic artery pseudoaneurysm management using coil embolization.
- This interventional radiology technique was performed without requiring surgical intervention.
Findings:
- Coil embolization proved effective in treating mycotic cystic artery pseudoaneurysm.
- The procedure successfully excluded the pseudoaneurysm without complications, preserving the need for surgery.
Implications:
- Coil embolization represents a viable, less invasive alternative to surgery for mycotic cystic artery pseudoaneurysm.
- This approach may become a preferred treatment modality, improving patient outcomes and reducing morbidity.
